Current filters:  
United States
Arnold & Porter
The Federal Circuit recently denied a rehearing and en banc petition in Molon Motor and Coil Corp. v. Nidec Motor Corp...
Jones Day
The Federal Circuit has definitively ruled on the PTAB's practice of allowing so-called "same-party" IPR joinder. The court held that an IPR petitioner cannot join itself as a party to an existing...
Jones Day
In three related final written decisions, the PTAB ruled that Bayer Healthcare ("Bayer") was not a real party in interest ("RPI") to IPR petitions filed by NOF Corporation, even though Bayer had a ...
Jones Day
On Monday, the Federal Circuit issued a per curiam order denying en banc rehearing that had been requested by all three of the parties to the ...
Akin Gump Strauss Hauer & Feld LLP
The Federal Circuit recently held certain method of treatment claims patent eligible under step one of Alice, reversing a district court's judgment on the pleadings.
Oblon, McClelland, Maier & Neustadt, L.L.P
On March 23, 2020, approximately two months after all briefs were submitted, the Fed. Cir. has denied the outstanding petitions for panel rehearing and rehearing ...
Buchanan Ingersoll & Rooney PC
The PTAB has provided guidance on the standard for exercising its discretion to deny institution under § 325(d).
Ropes & Gray LLP
The United States Patent and Trademark Office (USPTO) today announced extensions to the time allowed to file certain patent and trademark-related documents and to pay certain required fees.
RPX Corporation
Intellectual Ventures LLC (IV), through subsidiary Intellectual Ventures II LLC (IV II), has sued Dell (VMware) (6:20-cv-00220) over the provision of various products...
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
The USPTO launches the Expanding Innovation Hub, a new online platform available on the USPTO website...
Foley & Lardner
In Illumina, Inc. v. Ariosa Diagnostics, Inc., a divided panel of the Federal Circuit found claims directed to methods of preparing DNA samples for analysis satisfy the patent eligibility requirement
Pearl Cohen Zedek Latzer Baratz
The U.S. Supreme Court has ruled that individual state governments cannot be sued for copyright infringement
Arnold & Porter
The primary legislation governing the authorisation, marketing, sale and supply of pharmaceutical products by the US Food and Drug Administration (FDA)
Jones Day
On March 23, 2020, the Federal Circuit denied rehearing and rehearing en banc in Arthrex. Arthrex, Inc. v. Smith & Nephew, Inc., No. 18-2140, Order Denying Rehearing and Rehearing En Banc, Dkt. 115.
Bereskin & Parr LLP
In the United States, ever since the 2012 Supreme Court decision in Mayo v. Prometheus, many diagnostic method...
Buchanan Ingersoll & Rooney PC
The Court answered both questions in the negative, contrary to a decision rendered by the PTAB's Precedential Opinion Panel.
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
In Facebook, Inc. v. Windy City Innovations, LLC, No. 2018-1400 (Fed. Cir. Mar. 18, 2020) the Federal Circuit found that the text of 35 U.S.C. § 315(c) ...
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
On Wednesday March 18, 2020, the Federal Circuit held that the first decision released by Director Iancu and the USPTO Precedential Opinion Panel ("POP")...
Ropes & Gray LLP
Recently, the Federal Circuit in Philips v. Google (here) explained that the Patent Trial & Appeal Board (PTAB) may only institute trial on grounds presented in a trial petition.
Wolf, Greenfield & Sacks, P.C.
Yet another product configuration "mark" failed to clear the Section 2(e)(5) hurdle, as the Board affirmed a refusal of the proposed mark shown below
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Font Size:
Mondaq Social Media